Results 81 to 90 of about 929,362 (315)

PPAR? Downregulation by TGF in Fibroblast and Impaired Expression and Function in Systemic Sclerosis: A Novel Mechanism for Progressive Fibrogenesis [PDF]

open access: yes, 2010
The nuclear orphan receptor peroxisome proliferator-activated receptor-gamma (PPAR-γ) is expressed in multiple cell types in addition to adipocytes. Upon its activation by natural ligands such as fatty acids and eicosanoids, or by synthetic agonists such
A Galli   +75 more
core   +19 more sources

Learning Myelin Content in Multiple Sclerosis from Multimodal MRI through Adversarial Training [PDF]

open access: yes, 2018
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). A reliable measure of the tissue myelin content is therefore essential for the understanding of the physiopathology of MS, tracking progression and assessing treatment efficacy.
arxiv   +1 more source

Comparison of Time-to-First-Event and Recurrent Event Methods in Multiple Sclerosis Trials [PDF]

open access: yesarXiv, 2021
Suppression of disability progression is an important goal in the treatment of multiple sclerosis (MS). Randomized clinical trials in MS frequently use the time to the first confirmed disability progression (CDP) on the ordinal Expanded Disability Status Scale (EDSS) as an endpoint.
arxiv  

Disease progression in systemic sclerosis [PDF]

open access: yesRheumatology, 2021
Leeuwen, N.M. van   +8 more
openaire   +4 more sources

Progressive System Sclerosis - A Case Report

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2003
Progressive systemic sclerosis is a disease that involves connective tissues and.blood vessels leading to fibrosis. The skin as well as internal organs are involved.
Jyothi S Kumar, L Ashok, G P Mamatha
doaj  

Multiple Sclerosis Lesion Activity Segmentation with Attention-Guided Two-Path CNNs [PDF]

open access: yesarXiv, 2020
Multiple sclerosis is an inflammatory autoimmune demyelinating disease that is characterized by lesions in the central nervous system. Typically, magnetic resonance imaging (MRI) is used for tracking disease progression. Automatic image processing methods can be used to segment lesions and derive quantitative lesion parameters.
arxiv  

Evaluation of estimated glomerular filtration rate and clinical variables in systemic sclerosis patients [PDF]

open access: yes, 2016
Objectives: The most important renal complication of systemic sclerosis (SSc) is scleroderma renal crisis (SRC). Many patients demonstrate less severe renal complications, most likely associated with reduced renal blood flow and a consequent reduction in
Amoroso, Antonio   +7 more
core   +1 more source

Uncommon skeletal findings in systemic sclerosis (scleroderma)

open access: yesSouth African Journal of Radiology, 2002
Scleroderma or progressive systemic sclerosis is a diffuse disease characterised by excessive deposition of collagen and small-vessel arteritis. Systemic sclerosis is divided into two groups. 1.
Betsie van der Walt   +2 more
doaj   +1 more source

Bilateral resorption of mandibular angle in patient with systematic sclerosis - a case report

open access: yesJournal of Education, Health and Sport, 2022
Progressive systemic sclerosis (PSS) is chronic autoimmune disease affecting a connective tissue. The symptoms of PSS in orofacial area are: restricted mouth opening, xerostomia, facial asymmetry and problems with oral hygiene.
Karolina Futyma-Gąbka   +2 more
doaj   +1 more source

Role of growth factors in the pathogenesis of tissue fibrosis in systemic sclerosis. [PDF]

open access: yes, 2010
The most severe clinical and pathologic manifestations of systemic sclerosis (SSc) are the result of a fibrotic process characterized by the excessive and often progressive deposition of collagen and other connective tissue macromolecules in skin and ...
Castro, Susan V.   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy